Research presented at the Alzheimer’s Association International Conference 2022 (AAIC 2022) is providing new insight into dementia risk, prevalence, diagnosis, treatment, the long-term cognitive impact of COVID-19 and more.

As one of the more than 6 million Americans, including 190,000 New Jerseyans, living with Alzheimer’s, I know the devastation of this disease and other dementia.

Thankfully, over the last decade, since the passage of the National Alzheimer’s Project Act (NAPA) and the Alzheimer’s Accountability Act, Congress has made addressing Alzheimer’s and dementia a priority. With these two laws set to expire in 2025, people living with Alzheimer’s and their caregivers critically need updated legislation.

As we have seen from the research presented at AAIC 2022, when we invest in Alzheimer’s and dementia research, we gain valuable insights. The investment must continue.

Please join me and the Alzheimer’s Association and ask Congresswoman Mikie Sherrill to cosponsor the NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act.

To learn more and take action, visit the Alzheimer’s Association at alz.org/advocate.

Doreen Monks
Alzheimer’s Association Advocate and Alzheimer’s Congressional Team (ACT) Member – District 11